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A 63-year-old Caucasian woman with end-stage renal failure,
due to underlying urogenital malformation, requiring colo-
ileal cystoplasty and unilateral nephrectomy, had been
established on regular hemodialysis for 3 years, when she
presented with progressive increased facial pigmentation and
excessive fine facial hair growth, which had started after a
summer holiday. She also complained of painful blistering of
the skin, affecting both the dorsum of both her hands and
scalp. Although she dialyzed for 3 h twice a week using a
forearm fistula, she had a combined Kt/V41.2, due to her
residual urine output of 41.0 l/day. Before starting dialysis
she had received multiple blood transfusions to maintain her
hemoglobin. Regular medications included conjugated estro-
gen hormone-replacement therapy and furosemide. Medical
history included cholecystectomy and excision of malignant
melanoma.
On examination the bullae were clearly of varying age. The
newer lesions were tense, fluid-filled, and painful, but many
had ruptured spontaneously leaving shallow ulcers. Older
lesions were covered in scars and some showed scarring as
they healed. The blisters were located exclusively on sun-
exposed areas (dorsum of both hands and scalp). The facial
pigmentation was generalized and not suggestive of melasma
or post-inflammatory pigmentation. Her face and neck were
covered in fine, long, nonpigmented hair. The number and
severity of the blisters as well as the facial pigmentation and
hair growth had progressed over the previous 6 months
(Figures 1 and 2).
What is your diagnosis?
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Figure 1 | Tense fluid-filled vesicles and bullae. Figure 2 | Fine, long, non-pigmented hair.
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The Diagnosis | Porphyria cutanea tarda
Porphyria cutanea tarda (PCT) is an uncommon but well-
recognized complication in long-term dialysis patients.1 The
primary cause of this disorder is uroporphyrinogen decar-
boxylase deficiency, a cytosolic enzyme that converts
uroporphyrinogen III to coproporphyrinogen III, a key step
in the heme synthesis pathway. Autosomal dominant
inherited mutations in the uroporphyrinogen decarboxylase
gene account for 20% of cases in the general population,2
with the remaining 80% classified as sporadic. Factors
including alcohol abuse and excess iron increase the demand
for heme and the enzymes required for synthesis. Thus, a
combination of increased demand for and reduced activity of
uroporphyrinogen decarboxylase disrupts heme production
and allows by-products to accumulate, triggering the signs
and symptoms of PCT.3 The dermatological symptoms of
PCT are caused by a buildup of porphyrin compounds
(specifically uroporphyrinogen) close to the surface of the
skin. Owing to the highly conjugated structure of porphyrins,
with alternating single and double carbon bonds, these
compounds exhibit a deep purple color, resulting in
discoloration of the skin. Exposure to excess sunlight is
thought to lead to the production of reactive oxygen species
causing the tissue injury and blistering.
Other risk factors include infections with hepatitis C virus
and HIV, hemochromatosis drugs, particularly estrogen-con-
taining hormone replacement therapy, and metal toxicity
(aluminum and lead).4 Decreased hepatic uroporphyrinogen
decarboxylase activity is thought to be the main cause in dialysis
patients due to suppressive effects of iron excess, either the
result of repeated blood transfusion or direct infusion.5
A positive diagnosis of PCT in this case was supported
by the location of the blisters in sunlight-exposed
areas (scalp, dorsum of hands) triggered after a holiday
in the sun. Skin biopsy was not performed, although
histopathological changes can be diagnostic. Urine porphyrin
levels are not usually helpful in patients on dialysis,
unless there is significant residual urine output as in our
case, with levels of 1365 mg per day (4–5 times above the
upper limit of normal). Serum ferritin was increased at
2097 mg/l (normal 40–250), trace metal screen was normal
(serum aluminum 0.19 mmol/l, lead 0.24 mmol/l, zinc
12.4 mmol/l) as was liver imaging. Hepatitis and HIV viral
serology were negative.
Within 2 months, the skin blistering, facial pigmentation,
and hypertrichosis had all improved following treatment with
venesection and erythropoietin to reduce iron overload, low-
dose oral hydroxychloroquine, together with withdrawal of
hormone-replacement therapy and furosemide, and avoid-
ance of further sunlight exposure.
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